Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 5.4 | 4.2 | 4.2 | |
| Revenue growth | 28.2% | -0.4% | | |
| Cost of goods sold | 4.2 | 2.0 | 0.0 | |
| Gross profit | 1.2 | 2.2 | 4.2 | |
| Gross margin | 21.9% | 52.2% | 100.0% | |
| Selling, general and administrative | 30.1 | 22.9 | 5.5 | |
| Research and development | 8.0 | 6.5 | 2.9 | |
| EBITA | -24.6 | -27.4 | -4.7 | |
| EBITA margin | -458.5% | -654.3% | -111.3% | |
| Amortization of intangibles | 0.1 | 0.1 | | |
| EBIT | -24.8 | -27.6 | -4.7 | |
| EBIT margin | -461.1% | -657.6% | -111.3% | |
| Pre-tax income | -24.6 | -74.6 | -4.9 | |
| Income taxes | 0.0 | 0.0 | 0.0 | |
| Net income | -24.9 | -72.8 | -4.9 | |
| Net margin | -463.9% | -1738.2% | -116.0% | |
| |
| Diluted EPS | ($1.19) | ($4.37) | | |
| Shares outstanding (diluted) | 21.0 | 16.7 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|